BIOCRYST PHARM
BIOCRYST PHARM operates in Diversified Metals & Mining.
BIOCRYST PHARM - Asset Resilience Ratio
BIOCRYST PHARM (BO1) has an Asset Resilience Ratio of 47.46% as of September 2024. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2016–2023)
This chart shows how BIOCRYST PHARM's Asset Resilience Ratio has changed over time. Compare with other companies' asset resilience ratios.
Liquid Assets Composition Over Time
This chart breaks down BIOCRYST PHARM's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | €0.00 | 0% |
| Short-term Investments | €233.17 Million | 47.46% |
| Total Liquid Assets | €233.17 Million | 47.46% |
Asset Resilience Insights
- Very High Liquidity: BIOCRYST PHARM maintains exceptional liquid asset reserves at 47.46% of total assets.
- This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
- The company has significant short-term investments, indicating active treasury management.
BIOCRYST PHARM Industry Peers by Asset Resilience Ratio
Compare BIOCRYST PHARM's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
MANHATTAN ASSOC
BE:MHT |
Other | 0.00% |
|
TV BROADCAST
MU:TBCN |
Other | 2.06% |
|
FIRST CITIZENS BC A
BE:FC6A |
Other | 12.78% |
|
COSTCO WHSL
MU:CTO |
Other | 1.77% |
|
GOLDMAN SACHS GROUP - Dusseldorf Stock Exchang
DU:GOS |
Other | 1.39% |
|
Public Service Company of New Mexico PFD 4.58%
PINK:PNMXO |
Other | 0.43% |
Annual Asset Resilience Ratio for BIOCRYST PHARM (2016–2023)
The table below shows the annual Asset Resilience Ratio data for BIOCRYST PHARM.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2023-12-31 | 53.84% | €278.34 Million | €516.96 Million | +32.11pp |
| 2022-12-31 | 21.74% | €119.54 Million | €550.00 Million | +21.19pp |
| 2021-12-31 | 0.55% | €3.21 Million | €588.15 Million | -7.89pp |
| 2020-12-31 | 8.44% | €28.24 Million | €334.71 Million | -4.15pp |
| 2019-12-31 | 12.58% | €22.05 Million | €175.28 Million | -40.36pp |
| 2018-12-31 | 52.94% | €77.74 Million | €146.84 Million | +16.97pp |
| 2017-12-31 | 35.97% | €64.11 Million | €178.26 Million | -0.26pp |
| 2016-12-31 | 36.22% | €32.55 Million | €89.85 Million | -- |